Xenon Pharmaceuticals (XENE) Earnings Date & Reports

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XENE is expected to report earnings to rise 19.28% to -99 cents per share on August 07

Xenon Pharmaceuticals XENE Stock Earnings Reports

Q2'25

Est.

$-0.99

Q1'25

Beat

by $0.08

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.05

The last earnings report on May 13 showed earnings per share of -82 cents, beating the estimate of -91 cents. With 945.54K shares outstanding, the current market capitalization sits at 2.28B.

View a ticker or compare two or three

Compare

XENE